Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

Dermatologist Doris Day, M.D., likes Neova Crème de la Copper, with a proprietary Copper Peptide Complex that “stimulates ...

After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular ...

Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.

In the recent SOUL trial, the GLP-1 drug reduced the risk of MACE by 14% over 4 years. Next up: a possible obesity indication ...

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

Walmart will become the first U.S. retailer to sell an over-the-counter continuous glucose monitor in physical stores, as ...

The FDA has expanded the label for oral semaglutide (Rybelsus; Novo Nordisk) tablets 7 mg and 14 mg to reduce the risk of major adverse cardiovascular events (MACE) in adults with type 2 diabetes who ...